Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
XLV
59
HOLDINGS
10%
ALSO IN THNR
THNR
19
HOLDINGS
33%
ALSO IN XLV
SECTOR DRIFT (XLV minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.4% | 8.9% | 8.9% |
|
MERCK & CO. INC. | 5.6% | 5.1% | 5.1% |
|
ABBVIE INC | 7.3% | 5.0% | 5.0% |
|
AMGEN INC | 3.7% | 5.4% | 3.7% |
|
PFIZER INC | 2.5% | 4.7% | 2.5% |
XLV Overweight Relative to THNR
|
JOHNSON & JOHNSON | 10.4% |
|
ELI LILLY & CO | 6.6% |
|
UNITEDHEALTH GROUP INC | 6.0% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
ABBOTT LABORATORIES | 3.2% |
|
GILEAD SCIENCES INC | 2.8% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
ABBVIE INC | 2.3% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
XLV Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -9.1% |
 |
INNOVENT BIOLOGICS, INC. | -5.8% |
 |
CHINA PHARMACEUTICAL GROUP | -5.4% |
|
SCHOLAR ROCK HOLDING CORP. | -5.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -5.3% |
|
REGENERON PHARMACEUTICALS | -4.8% |
|
VIKING THERAPEUTICS, INC. | -4.5% |
|
HIMS & HERS HEALTH, INC. CLASS A | -4.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.2% |
 |
ASTRAZENECA PLC | -3.9% |